Growth-hormone axis · Peptide
Hexarelin
A potent growth-hormone-releasing peptide with cardiac-research interest.
Status as of 2026-07 · reclassification ≠ FDA approval · educational only, not medical advice.
The signal it sends
Strong GH-secretagogue receptor agonist; also studied for direct heart effects.
Benefits & effects studied
- Strong GH release
- Cardiac-protective research interest
Research state
Early research; desensitization with continuous use noted. Not approved.
Dosing & pharmacokinetics
Limited short cycles in protocols. Half-life: Short.
Dosing information is educational only. Hexarelin decisions belong with a licensed clinician — Jevity does not recommend or supply dosing.
History & discovery
First described early 1990s by Romano Deghenghi and colleagues (Europeptides; with Mediolanum Farmaceutici) Origin: Developed in the early 1990s by Romano Deghenghi's team at Europeptides as a more stable analog of GHRP-6, incorporating a 2-methyl-D-tryptophan substitution for enhanced potency and durability..
Molecular structure
A synthetic six-amino-acid peptide (hexapeptide) growth hormone secretagogue, His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2.
Frequently asked questions
Is Hexarelin FDA-approved?
Not FDA-approved — research use only On Jevity's evidence scale, Hexarelin is graded "Early / limited human data". Reclassification for compounding is not the same as FDA approval.
What is Hexarelin used for?
A potent growth-hormone-releasing peptide with cardiac-research interest. Strong GH-secretagogue receptor agonist; also studied for direct heart effects. Studied effects include: Strong GH release; Cardiac-protective research interest. This is educational information, not a recommendation to use it.
Is Hexarelin legal in the UAE?
UAE / DHA status: Prescription-only via a DHA-licensed clinic
Is Hexarelin banned in sport?
WADA status: Prohibited at all times (GH axis)
What is Hexarelin's Jevity Score?
Hexarelin has a Jevity Score of 37/100 — a proprietary composite of evidence strength (4/10), regulatory clarity (3/10) and supply verifiability (4/10). It reflects how established and legitimate the compound is, not a recommendation.
Hexarelin is prescription-only or research-only. A licensed clinician must evaluate whether it's appropriate for you.
Book a consult →Related growth-hormone axis peptides
Educational information only — not medical advice, a diagnosis, or a recommendation to use any substance or therapy. Regulatory status changes; verify current rules and any personal decision with a licensed clinician. Jevity is operated by Upcapital Global FZCO, Dubai, UAE.